• Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.

    Simple item page

    Files

    Original bundle

    Now showing 1 - 1 of 1
    Thumbnail Image
    Name:
    Eustace A et al (2018).pdf
    Size:
    1.73 MB
    Format:
    Adobe Portable Document Format
    Description:
    Download

    License bundle

    Now showing 1 - 1 of 1
    Thumbnail Image
    Name:
    license.txt
    Size:
    3.5 KB
    Format:
    Item-specific license agreed upon to submission
    Description:
    Download

    Collections

    Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
    RSS Feeds